Clinical trial
Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With…
NCT00214981 · Cephalon, Industry · Completed
Key facts
| NCT number | NCT00214981 |
|---|---|
| Title | Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD |
| Official title | A 1-Year, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Continued Efficacy of Modafinil (Film-coated Tablet Formulation) in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (Followed by an Open-Ended Extension Period) |
| Lead sponsor | Cephalon, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Attention Deficit/Hyperactivity Disorder, ADHD |
| Intervention type | Drug |
| Interventions | Modafinil |
| Start date | Sep 1, 2003 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 26, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: